IndraLab

Statements

USP37 inhibits sensitivity cisplatin. 1 / 1

| 1

➶

eidos

"USP37 knockdown inhibits tumorigenicity and increases sensitivity to cisplatin in vivo ."

30482232

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP37 inhibits sensitivity cisplatin. 1 / 1

INDRA sources:

Databases

Reading